← SynDRA
METOPRINE
SynDRA canonical compound SYN0002258 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | DHFR | HNMT |
| Mechanism of action | histamine n-methyltransferase inhibitor |
| Indication | renal cell carcinoma (rcc) |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- histamine n-methyltransferase inhibitor
- PDF INHIBITOR
- HNMT INHIBITOR
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
- Folic Acid Antagonists
Cross-references
Synonyms
- NSC-19494
- NSC-7364
- TCMDC-123931
- Methodichlorophen
- DDMP
- Metoprine [USAN]
- BW 197U
- NSC 19494
- SK 5265
- 5-(3,4-DICHLOROPHENYL)-6-METHYLPYRIMIDINE-2,4-DIAMINE
- U-197
- NSC7364
- UNII-2L9RKX796Q
- Metoprine (USAN)
- BW 50-197
- METOPRINE, METHODICHLOROPHEN
- 5-(3,4-Dichlorophenyl)-6-methyl-2,4-pyrimidinediamine
- NSC 7364
- 2,4-Pyrimidinediamine, 5-(3,4-dichlorophenyl)-6-methyl-
- BW50197
- BRN 0223622
- 5-(3,4-Dichlorphenyl)-6-methyl-2,4-pyrimidindiamin
- 2,4-Diamino-5-(3,4-dichlorophenyl)-6-methylpyrimidine
- MLS002701892
- BW 197 U
- BW 1970
- BW 50197
- BW 50,197
- 2,4-Diamino-5-(3',4'-dichlorophenyl)-6-methyl pyrimidine
- Chloroaniline 1
- 2L9RKX796Q
- NSC19494
- DTXCID1031620
- RefChem:158389
- 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine
- C11H10Cl2N4
- 5-(3,4-dichlorophenyl)-6-methyl-pyrimidine-2,4-diamine
- 2,4-dichlorophenyl)-6-methylpyrimidine
- 2, 5-(3,4-dichlorophenyl)-6-methyl-
Look up METOPRINE in the interactive SynDRA portal →